• LOGIN
    Login with username and password
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publications
  • Projects
  • Research Data
  • Organizations
  • Researchers
  • More
  • Statistics
  • LOGIN
    Login with username and password
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. Evaluation of treatment response and symptom progression in 400 patients with visual snow syndrome.
 

Evaluation of treatment response and symptom progression in 400 patients with visual snow syndrome.

Options
  • Details
  • Files
BORIS DOI
10.48350/161920
Publisher DOI
10.1136/bjophthalmol-2020-318653
PubMed ID
34656983
Description
AIMS

To gather information on useful medications to treat visual snow syndrome (VSS) as well as to validate an instrument to assess its clinical severity and the course of the disorder over time.

METHODS

Four hundred patients with VSS were included in this web-based prospective questionnaire study. All subjects completed a treatment questionnaire and a clinical diary. The first allowed evaluation of the effects of previous medications on visual snow, while the second measured VSS symptoms daily over the course of 30 days.

RESULTS

Patients commonly reported previous use of medications such as antidepressants, antiepileptics, antibiotics and benzodiazepines. However, none of these drug classes was beneficial for the majority of patients. Recreational drugs and alcohol worsened visual snow symptoms in several reports. Vitamins and benzodiazepines had high therapeutic ratios, although in most cases they did not change the course of VSS.The monthly diary confirmed that the static in VSS is a consistent symptom over time. It also showed that indoor and fluorescent lights have a worse effect on symptoms when compared with natural outdoor lighting.

CONCLUSIONS

The study confirms clinical experience that medications are generally ineffective in VSS, with the exception of vitamins and perhaps benzodiazepines, which could be beneficial in some patients. The 30-day diary represents a useful tool to measure symptom progression over time, which could be used in future trials on VSS.
Date of Publication
2022-09
Publication Type
Article
Subject(s)
600 - Technology::610 - Medicine & health
Keyword(s)
treatment other visual pathway
Language(s)
en
Contributor(s)
Puledda, Francesca
Vandenbussche, Nicolas
Moreno-Ajona, David
Eren, Ozan
Schankin, Christoph Josef
Universitätsklinik für Neurologie
Goadsby, Peter J
Additional Credits
Universitätsklinik für Neurologie
Series
The British journal of ophthalmology
Publisher
BMJ Publishing Group
ISSN
1468-2079
Access(Rights)
open.access
Show full item
BORIS Portal
Bern Open Repository and Information System
Build: ae9592 [15.12. 16:43]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
  • Audiovisual Material
  • Software & other digital items
More
  • About BORIS Portal
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo